• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Allergan

Allergan

Allergan AGN 2 Star

Last Price$127.80Day Change (%)3.09%
Open Price$124.31Day Change ($)3.83
Day Range123.97–127.9652-Week Range81.33–132.04

As of Tue 04/15/2014 03:34 PM EST | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Allergan Announces Quarterly Conference Call

    Allergan Announces Quarterly Conference Call

  2. UPDATE: J.P. Morgan down on results; Zoe's surges on debut

    UPDATE: J.P. Morgan down on results; Zoe's surges on debut

  3. UPDATE: J.P. Morgan down on results; Zoe's surges on debut

    UPDATE: J.P. Morgan down on results; Zoe's surges on debut

  4. Credit Market Outlook: Bonds Priced for the Benign

    Corporate credit spreads are fairly valued--albeit at the tight end of the range that we view as fairly valued.

  5. Hagens Berman: Pharmaceutical Company SkinMedica Selling Misbranded Drug Products as Cosmeceuticals

    Hagens Berman: Pharmaceutical Company SkinMedica Selling Misbranded Drug Products as Cosmeceuticals

  6. Allergan Defends Its Territory Against Increased Competition

    Brand recognition and product innovation keep the firm's moat wide.

  7. 10 High-Conviction Purchases by Our Ultimate Stock-Pickers

    Our top managers continue to put money into wide-moat firms.

  8. Valeant's Ambitious 2016 Goal Excites Investors

    While guidance for 2014 meets expectations, Valeant sets its sights on becoming a top-five global pharmaceutical company.

  9. Ideas From the Wide Moat Focus Index

    Morningstar StockInvestor editor Matt Coffina discusses recent additions to the Wide Moat Focus Index.

  10. Bausch & Lomb Purchase Highlights Value-Creation Ability of Valeant's Moat

    Ophthalmology will be more challenging for Valeant than dermatology, but the deal is highly accretive.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.